Dr Monika Tschochner




  • Tschochner, M., Leary, S., Cooper, D., Strautins, K., Chopra, A., Clark, H., Choo, L., Dunn, D., James, I., Carroll, W., Kermode, A., Nolan, D., (2016), Identifying patient-specific Epstein-Barr Nuclear antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis, PLoS One, 11, 2, pages 1 - 22.
  • Strautins, K., Tschochner, M., James, I., Choo, L., Dunn, D., Kermode, A., Carroll, W., Nolan, D., (2014), Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk, Multiple Sclerosis Journal, 20, 3, pages 286 - 294.
  • Keane, N., Roberts, S., Almeida, C., Krishnan, T., Chopra, A., Tulloch, E., Pavlos, R., Tschochner, M., Carlson, J., Mallal, S., Heckerman, D., James, I., John, M., (2012), High-avidity, high-IFN-producing CD8 T-cell responses following immune selection during HIV-1 infection, Immunology and Cell Biology, 90, 2, pages 224 - 234.
  • Nolan, D., Castley, A., Tschochner, M., James, I., Qiu, W., Sayer, D., Christiansen, F., Witt, C., Mastaglia, F., Carroll, W., Kermode, A., (2012), Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk, Neurology, 79, 6, pages 538 - 546.
  • Tschochner, M., Chopra, A., Maiden, T., Ahmad, I., James, I., Furrer, H., Gunthard, H., Mallal, S., Rauch, A., John, M., (2009), Effects of HIV type-1 immune selection on susceptibility to integrase inhibitor resistance, Antiviral Therapy, 14, 7, pages 953 - 964.